Hawa Diallo
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways
Most-Cited Works
- → A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response(2012)940 cited
- → Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides(2011)176 cited
- → Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors(2015)83 cited
- → Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors(2015)79 cited
- → A Chemical Probe for the ATAD2 Bromodomain(2016)75 cited
- → GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain(2016)65 cited
- → Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives(2016)59 cited
- → Structure- and property-based design of factor Xa inhibitors: Pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs(2006)40 cited
- → Structure and property based design of factor Xa inhibitors: Biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs(2007)23 cited
- → Kruidenier et al. reply(2014)19 cited